SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012477
Filing Date
2016-04-22
Accepted
2016-04-22 16:18:04
Documents
4
Period of Report
2016-06-14
Effectiveness Date
2016-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228323zdef14a.htm DEF 14A 562497
2 G457268.JPG g457268.jpg GRAPHIC 4942
3 G24582BII001.GIF g24582bii001.gif GRAPHIC 91286
4 G24582BII002.GIF g24582bii002.gif GRAPHIC 93280
  Complete submission text file 0001047469-16-012477.txt   825004
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35119 | Film No.: 161586896
SIC: 2834 Pharmaceutical Preparations